tiprankstipranks
Trending News
More News >
Kuraray Co (JP:3405)
:3405

Kuraray Co (3405) AI Stock Analysis

Compare
0 Followers

Top Page

JP:3405

Kuraray Co

(OTC:3405)

Select Model
Select Model
Select Model
Neutral 62 (OpenAI - 4o)
Rating:62Neutral
Price Target:
¥1,867.00
▲(12.10% Upside)
Kuraray Co's overall stock score is driven by stable financial performance with strong operating margins and a solid balance sheet. However, technical indicators suggest bearish momentum, and the high P/E ratio indicates potential overvaluation. The dividend yield provides some support to the valuation.
Positive Factors
Revenue Growth
Consistent revenue growth indicates strong market demand and effective business strategies, supporting long-term financial stability.
Strong Balance Sheet
A strong balance sheet with moderate leverage provides financial stability and flexibility for future investments and growth.
Operating Margins
Sustained operating margins reflect efficient cost management and robust core operations, enhancing long-term profitability.
Negative Factors
Low Return on Equity
Low ROE suggests inefficiency in using shareholders' equity to generate profits, potentially limiting investor returns and growth.
Decline in Free Cash Flow
A decline in free cash flow can constrain the company's ability to fund new projects, pay dividends, or reduce debt, impacting future growth.
Net Profit Margin Decline
A declining net profit margin indicates rising costs or inefficiencies, which could pressure profitability and affect competitive positioning.

Kuraray Co (3405) vs. iShares MSCI Japan ETF (EWJ)

Kuraray Co Business Overview & Revenue Model

Company DescriptionKuraray Co., Ltd. is a Japanese chemical company that specializes in the production of advanced materials and specialty chemicals. Established in 1926, Kuraray operates in various sectors including healthcare, fibers and textiles, and industrial materials. The company's core products include polyvinyl alcohol (PVA) resins, which are used in a wide range of applications such as packaging, textiles, and construction, as well as medical products and high-performance materials for various industries.
How the Company Makes MoneyKuraray generates revenue primarily through the sale of its specialty chemicals and advanced materials across multiple sectors. Its key revenue streams include the manufacturing and sale of PVA resins, which are critical in industries such as packaging and textiles, as well as medical and pharmaceutical products. The company also earns income from its investments in healthcare, including dental and medical supplies. Significant partnerships with various industrial clients and healthcare providers enhance Kuraray’s market reach and contribute to its earnings. Additionally, the company’s focus on innovation and development of new products helps to maintain competitive advantages and drive revenue growth.

Kuraray Co Financial Statement Overview

Summary
Kuraray Co shows consistent revenue growth and strong operating margins. The balance sheet is solid with moderate leverage, but low ROE suggests inefficiency in using equity. Cash flow is strong, though slight declines in free cash flow growth need attention.
Income Statement
75
Positive
Kuraray Co has demonstrated a consistent revenue growth trajectory with a 5.88% increase from 2023 to 2024. The gross profit margin for 2024 is 32.35%, indicating strong profitability in its core operations. However, the net profit margin declined to 3.84% in 2024 from the previous year, reflecting increased expenses or potential inefficiencies. The EBIT margin is stable at 10.29%, and the EBITDA margin is 20.60%, showcasing healthy operating performance.
Balance Sheet
70
Positive
The company maintains a solid equity base with an equity ratio of 59.22%, indicating a strong balance sheet. The debt-to-equity ratio is 0.32, suggesting moderate leverage and financial stability. However, the return on equity (ROE) is relatively low at 4.15%, which may indicate underutilization of equity to generate profits.
Cash Flow
65
Positive
Kuraray Co's free cash flow declined slightly by 2.67% from 2023 to 2024, showing some pressure on liquidity. The operating cash flow to net income ratio is 4.36, indicating strong cash generation relative to net income. However, the free cash flow to net income ratio is 2.11, suggesting less efficient translation of profits into free cash flow.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue815.64B826.89B780.94B756.38B629.37B541.80B
Gross Profit251.87B267.52B239.98B241.66B204.14B165.41B
EBITDA139.79B141.17B141.25B144.91B119.33B73.03B
Net Income15.32B31.72B42.45B54.31B37.26B2.57B
Balance Sheet
Total Assets1.26T1.29T1.25T1.22T1.09T1.05T
Cash, Cash Equivalents and Short-Term Investments115.00B121.69B134.62B128.58B155.80B192.24B
Total Debt265.64B244.28B282.02B324.40B307.44B341.39B
Total Liabilities510.32B509.45B518.33B553.00B511.41B536.11B
Stockholders Equity730.13B764.28B714.63B647.09B560.40B499.13B
Cash Flow
Free Cash Flow0.0066.91B68.75B-20.93B8.04B-4.97B
Operating Cash Flow0.00138.29B129.30B51.73B78.22B79.95B
Investing Cash Flow0.00-76.01B-63.15B-68.62B-65.59B-64.03B
Financing Cash Flow0.00-82.50B-64.96B-12.05B-47.45B91.51B

Kuraray Co Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price1665.50
Price Trends
50DMA
1635.35
Negative
100DMA
1714.08
Negative
200DMA
1742.84
Negative
Market Momentum
MACD
-24.61
Negative
RSI
47.51
Neutral
STOCH
85.76
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:3405, the sentiment is Neutral. The current price of 1665.5 is above the 20-day moving average (MA) of 1550.85, above the 50-day MA of 1635.35, and below the 200-day MA of 1742.84, indicating a neutral trend. The MACD of -24.61 indicates Negative momentum. The RSI at 47.51 is Neutral, neither overbought nor oversold. The STOCH value of 85.76 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for JP:3405.

Kuraray Co Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
72
Outperform
¥700.00B15.5519.69%3.28%10.06%18.03%
72
Outperform
$1.13T104.961.67%1.01%-1.90%-71.97%
71
Outperform
$715.65B17.714.79%4.27%-1.21%-27.21%
69
Neutral
¥756.34B8.928.79%2.56%-1.64%
62
Neutral
¥478.41B61.721.08%3.44%-1.94%-84.08%
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
54
Neutral
$1.12T10.251.09%3.67%-11.50%25.86%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:3405
Kuraray Co
1,571.00
-701.49
-30.87%
JP:4188
Mitsubishi Chemical Holdings
872.50
107.91
14.11%
JP:4021
Nissan Chemical
5,306.00
299.99
5.99%
JP:4004
Showa Denko KK
6,406.00
2,316.89
56.66%
JP:4005
Sumitomo Chemical Co
468.90
126.54
36.96%
JP:4042
Tosoh
2,339.50
346.47
17.38%

Kuraray Co Corporate Events

Kuraray Co. to Cancel 16.9 Million Treasury Shares
Nov 12, 2025

Kuraray Co., Ltd. has announced the cancellation of 16,900,000 shares of its treasury stock, which represents 5.20% of its total issued and outstanding shares. This move, set to take place on November 28, 2025, is part of the company’s efforts to manage its capital structure and potentially enhance shareholder value.

Kuraray Co. Reports Decline in Nine-Month Financial Performance
Nov 12, 2025

Kuraray Co., Ltd. reported a decline in its financial performance for the nine months ending September 30, 2025, with net sales decreasing by 3.5% and operating income dropping by 37.3% compared to the previous year. The company’s net income attributable to owners fell by 51.1%, reflecting challenges in maintaining profitability amidst changing market conditions.

Kuraray Co. to Receive Significant Dividend from European Subsidiary
Sep 25, 2025

Kuraray Co., Ltd. announced it will receive a dividend from its subsidiary, Kuraray Europe GmbH, amounting to EUR 300 million in November 2025. This dividend will result in approximately JPY 51.4 billion being recorded as non-operating income in Kuraray’s unconsolidated financial results for the fiscal year ending December 31, 2025, but it will not impact the consolidated business performance.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Oct 10, 2025